The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of adjuvant chemotherapy on prognosis in patients with familial pancreatic cancer.
 
Yuya Miura
Employment - TRANSGENIC INC. (I)
 
Yukiyasu Okamura
Speakers' Bureau - Asahi Kasei; AstraZeneca; Chugai Pharma; Eisai; Johnson & Johnson/Janssen; Medtronic; Taiho Pharmaceutical; Takeda; TERUMO; Tsumura & Co.
Research Funding - Chugai Pharma (Inst); Miyarisan pharmaceutical (Inst); Nihonkayaku (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); TERUMO (Inst)
 
Nao Yoshida
No Relationships to Disclose
 
Kei Saito
No Relationships to Disclose
 
Teiichi Sugiura
No Relationships to Disclose
 
Kanae Inoue
Speakers' Bureau - Chugai Pharma
 
Kei Nakagawa
Speakers' Bureau - AstraZeneca; Incyte; Taiho Pharmaceutical
 
Keiko Kamei
No Relationships to Disclose
 
Hideki Ueno
No Relationships to Disclose
 
Satoshi Kobayashi
No Relationships to Disclose
 
Kazuyuki Nagai
No Relationships to Disclose
 
Shingo Kagawa
No Relationships to Disclose
 
Toru Otsuru
No Relationships to Disclose
 
Hirofumi Shirakawa
No Relationships to Disclose
 
Shunichiro Orihara
No Relationships to Disclose
 
Masataka Taguri
No Relationships to Disclose
 
Hiroaki Yanagimoto
No Relationships to Disclose
 
Naohiro Okano
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Chigusa Morizane
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Guardant Health; Konica Minolta; MSD K.K.; Myriad Genetics; Novartis; SERVIER; Sysmex; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; BioNTech SE; Boehringer Ingelheim; Pfizer; Revolution Medicines; SERVIER; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo RD Novare (Inst); Eisai (Inst); EPS Corporation (Inst); Hitachi (Inst); LabCorp (Inst); ONO PHARMACEUTICAL (Inst); Taiho Pharmaceutical (Inst)
 
Junji Furuse
Honoraria - Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; J-Pharma; MSD; Novartis; Ohara Pharmaceutical; SERVIER; Taiho Pharmaceutical; Takeda; Teijin Pharma
Consulting or Advisory Role - Astellas Pharma; Delta-Fly Pharma; Eisai; J-Pharma; OncoTherapy Science